Abstract
We studied the effect of the pyridoindole antioxidant stobadine on glycation-induced absorbance and fluorescence changes in bovine serum albumin (BSA), used as a model protein. Incubation of BSA (4 mg/ml) with glucose (100–400 mM) in 0.12 M phosphate buffer, pH 7.4, in the presence of 100 μM Cu2+ at 37°C resulted in a time-dependent increase of absorbance (320 nm) and fluorescence (excitation 350 nm, emission 415 nm). The process was found to be dependent on the presence of oxygen and transition metal ions, but equimolar iron could not fully substitute for the activity of copper. The glucose-induced chromo- and fluorophore formation was reduced significantly by stobadine. For 200 mM glucose, in 7- and 14-day incubations, 51%–60% inhibition was obtained at a stobadine concentration of 0.1 mM, and the effect leveled off at higher concentrations of the drug. No inhibition was observed withN-acetyl stobadine, a derivative with restricted antioxidant activity. Since stobadine did not affect the Amadori product formation determined by the thiobarbituric acid (TBA) method as 5-hydroxymethyl furfural (5-HMF) released in boiling oxalic acid, the inhibitory action of stobadine may be explained by its interference with metal-catalyzed oxidation reactions following after the glycation step. The results obtained suggest that antioxidant therapy could be used to limit the damage from adverse glycation-induced processes in diabetes mellitus.
Similar content being viewed by others
References
Brovnlee M, Glycation of macromolecules. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds) International textbook of diabetes mellitus. Wiley, Chichester, pp 669–684, 1992
Baynes JW, Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412, 1991
Wolff SP, Jiang ZY, Hunt JV, Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 10:339–352, 1991
Hunt JV, Bottoms MA, Mitchinson MJ, Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Biochem J 291:529–535, 1993
Fu MX, Wells-Knecht KJ, Thorpe SR, Baynes JW, Role of oxygen in cross-linking and chemical modification of collagen by glucose. Diabetes 4 (Suppl 2):42–48, 1992
Fu MX, Wells-Knecht KJ, Blackledge JA, Lyons TJ, Thorpe SR, Baynes JW, Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanism, and inhibition of late stages of the Maillard reaction. Diabetes 43:676–683, 1994
Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW, Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 34:3702–3709, 1995
Grandhee SK, Monnier VM, Mechanism of formation of the Maillard protein cross-link pentosidine. J Biol Chem 266:11649–11653, 1991
Dyer DG, Blackledge JA, Thorpe SR, Baynes JW, Formation of pentosidine during nonenzymatic browning of proteins by glucose. J Biol Chem 266:11654–11660, 1991
Oddetti P, Fogarty J, Sell DR, Monnier VM, Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 41:153–160, 1992
Sell DR, Lapolla A, Odetti P, Fogarty J, Monnier VM, Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes 41:1286–1292, 1992
Beisswenger PJ, Moore LL, Brick-Johnsen T, Curphey TJ, Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 92:212–217, 1993
Sell DR, Carlson EC, Monnier VM, Differential effects of type 2 (non-insulin-dependent) diabetes mellitus on pentosidine formation in skin and glomerulal basement membrane. Diabeteologia 36:936–941, 1993
McCance DR, Dyer DG, Dunn JA, Bailie KE, Thorpe SR, Baynes JW, Lyons TJ, Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91:2470–2478, 1993
Takahashi M, Ohishi T, Aoshima H, Kawana K, Kushida K, Inoue T, Horiuchi K,The Maillard protein cross-link pentosidine in urine from diabetic patients. Diabetologia 36:664–667, 1993
Hunt JV, Dean RT, Wolff SP, Hydroxyl radical production and autoxidative glycosylation. Biochem J 256:205–212, 1988
Giugliano D, Ceriello A, Paolisso G, Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress. Metabolism 44:363–368, 1995
Maxwell SR, Prospects for the use of antioxidant therapies. Drugs 49: 345–361, 1995
Jahodnik I, Stefek M, Stobadine—an inhibitor of oxidative damage of proteins. Cs Physiol 42:147, 1993
Horakova L, Sies H, Steenken S, Antioxidant action of stobadine. In: Packer L (ed) Methods in enzymology, Vol 234. Academic Press, London, pp 572–580, 1994
Wolff SP, Dean RT, Glucose autoxidation and protein modification. The potential role of autoxidative glycosylation in diabetes. Biochem J 245:243–250, 1987
Furth AJ, Methods for assaying nonenzymatic glycosylation. Anal Biochem 175:347–360, 1988
Sakurai T, Takahashi H, Tsuchiya S, New fluorescence of nonenzymatically glucosylated serum albumin. FEBS Lett 176:27–31, 1984
Smith PC, Wang C, Nonenzymatic glycation of albumin by acyl glucuronides in vitro. Comparison of reactions with reducing sugars. Biochem Pharmacol 44:1661–1668, 1992
Brownlee M, Glycation and diabetic complications. Diabetes 43:836–841, 1994
Marx G, Chevion M, Site-specific modification of albumin by free radicals. Reactions with copper II and ascorbate. Biochem J 236:397–400, 1986
Carter DC, Ho JX, Structure of serum albumin. Adv Prot Chem 45:153–203, 1994
Chace KV, Carubelli R, Nordquist RE, The role of nonenzymatic glycosylation, transition metals and free radicals in the formation of collagen aggregates. Arch Biochem Biophys 288:473–480, 1991
Stasko A, Ondrias K, Misik V, Szocsova H, Gergel D, Stobadine — a novel scavenger of free radicals. Chem Papers 44:493–500, 1990
Steenken S, Sundquist AR, Jovanovic SV, Crockett R, Sies H, Antioxidant activity of the pyridoindole stobadine. Pulse radiolytic characterization of one-electron-oxidized stobadine and quenching of singlet molecular oxygen. Chem Res Toxicol 5:355–360, 1992
Stefek M, Benes L, Pyridoindole stobadine is a potent scavenger of hydroxyl radicals. FEBS Lett 294:264–266, 1991
Stefek M, Masarykova M, Benes L, Inhibition of cumene hydroperoxide-induced lipid peroxidation by a novel pyridoindole antioxidant in rat liver microsomes. Pharmacol Toxicol 70:407–411, 1992
Stefek M, Trnkova Z, Inhibition of alloxan-induced hyperglycaemia in mice by the pyridoindole stobadine. Pharmacol Toxicol 77:320–322, 1995
Kagan VE, Tsuchiya M, Serbinova E, Packer L, Sies H, Interaction of the pyridoindole stobadine with peroxyl, superoxide and chromanoxyl radicals. Biochem Pharmacol 45:393–400, 1993
Horakova L, Briviba K, Sies H, Antioxidant activity of the pyridoindole stobadine in liposomal and microsomal lipid peroxidation. Chem Biol Interact 83:85–93, 1992
Kallay Z, Bittererova J, Brejcha A, Faberova V, Bezek S, Trnovec T, Plasma concentration, tissue distribution and excretion of the prospective cardioprotective agentcis-(-)-2,3,4,4a,5,9b-hexahydro-2,8-dimethyl-1H-pyrido[4, 3b] indole dihydrochloride in rats. Arzneimittelforschung 40 (II):974–979, 1990
Stefek M, Benes L, Kocis P, Biotransformation of stobadine in vivo. Cs Physiol 35:367, 1986
Stefek M, Benes L, Jergelova M, Scasnar V, Turi-Nagy L, Kocis P, Biotransformation of stobadine in rat liver microsomes. Xenobiotica 17:1067–1073, 1987
Stefek M, Benes L, Zelnik V, N-oxygenation of stobadine, a gamma-carboline antiarrhythmic and cardioprotective agent: the role of flavin-containing monooxygenase. Xenobiotica 19:143–150, 1989
Gajdosikova A, Ujhazy E, Gajdosik A, Chalupa I, Blasko M, Tomaskova A, Liska J, Dubovicky M, Bauer V, Chronic toxicity and micronucleus assay of the new cardioprotective agent stobadine in rats. Arzneimittelforschung 45 (1):531–536, 1995
Ujhazy E, Dubovicky M, Balonova T, Jansak J, Zeljenkova D, Teratological assessment of stobadine after single and repeated administration in mice. J Appl Toxicol 14:357–363, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stefek, M., Drozdikova, I. & Vajdova, K. The pyridoindole antioxidant stobadine inhibited glycation-induced absorbance and fluorescence changes in albumin. Acta Diabetol 33, 35–40 (1996). https://doi.org/10.1007/BF00571938
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00571938